# Seroprevalence and Incidence of Lassa Fever in the Rural Commune of Sibirila, District of Bougouni, Mali

> **NCT02311387** · — · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 601 (actual)

## Conditions studied

- Lassa Virus Infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02311387
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12-05
- **Primary completion:** 2016-10-31
- **Final completion:** 2018-10-22
- **Target enrollment:** 601 (ACTUAL)
- **Last updated:** 2019-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02311387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02311387, "Seroprevalence and Incidence of Lassa Fever in the Rural Commune of Sibirila, District of Bougouni, Mali". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02311387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*